Related Experiment Video
Updated: Sep 27, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Colorectal Cancer Is Associated with the Presence of Cancer Driver Mutations in Normal Colon
Julia Matas1,2, Brendan Kohrn1, Jeanne Fredrickson1
1Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington.
Normal colon tissue from patients with colorectal cancer harbors more mutations than healthy tissue. Ultrasensitive testing reveals these early genetic changes may predict cancer risk.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Somatic mutations in colorectal cancer are known, but their presence in normal colon tissue prior to cancer development is poorly understood.
- Understanding early mutational events in the colon is crucial for identifying individuals at higher risk for colorectal cancer.
Purpose of the Study:
- To investigate the accumulation and characteristics of somatic mutations in normal colon tissue.
- To determine if these mutations differ between individuals with and without colorectal cancer.
- To explore the potential of ultrasensitive mutation detection for predicting colorectal cancer risk.
Main Methods:
- Development and application of an ultrasensitive, single-molecule mutational test utilizing CRISPR-DS technology.
- Detection of mutations at very low frequencies (<0.001) in normal colon tissue samples.
- Analysis of mutations in common colorectal cancer genes, including KRAS and TP53.
Main Results:
- Normal colon tissue from both cancer patients and healthy individuals contains mutations in common colorectal cancer genes.
- Mutations are significantly more abundant in normal colon tissue from patients with colorectal cancer.
- Oncogenic KRAS mutations were found in approximately one-third of normal colon samples from colorectal cancer patients, but none from healthy controls.
- TP53 mutations were more frequent, pathogenic, and formed larger clones in patients with colorectal cancer, particularly early-onset cases.
- Most mutations in normal colon tissue were distinct from tumor driver mutations, suggesting independent clonal evolution.
Conclusions:
- Somatic evolution and clonal expansion occur in the normal colon, a process enhanced in individuals who develop colorectal cancer.
- The presence of pathogenic KRAS and TP53 mutations in normal colon tissue is a common event preceding colorectal cancer development.
- Ultrasensitive gene sequencing of normal colon tissue shows promise for predicting colorectal cancer risk, especially for early-onset disease.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

